NCT05225311View on ClinicalTrials.gov

Fetal Ebstein Anomaly and Tricuspid Valve Dysplasia Registry

RecruitingOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

September 22, 2021

Primary Completion Date

September 30, 2050

Study Completion Date

September 30, 2055

Conditions
Ebstein AnomalyTricuspid Valve Dysplasia
Interventions
OTHER

Observation

Patients will be followed by the registry for life-long outcomes.

Trial Locations (1)

M5G1X8

RECRUITING

The Hospital for Sick Children, Toronto

All Listed Sponsors
lead

The Hospital for Sick Children

OTHER